“…However, emergence of non-vaccine serotypes, particularly serotype 19A, has been noted in many parts of the world including North America, 1,2 Europe, [3][4][5][6][7] Oceania, 8 Latin America, 9 and Asia. [10][11][12] The emergent serotype 19A was associated with a higher rate of penicillin nonsusceptibity. [13][14][15] Other non-vaccine serotype have been identified to increase penicillin nonsusceptibility of invasive pneumococci in the post PCV7 era.…”